Skip to main content
  • Research article
  • Open access
  • Published:

A whole-body diffusion MRI normal atlas: development, evaluation and initial use

Abstract

Background

Statistical atlases can provide population-based descriptions of healthy volunteers and/or patients and can be used for region- and voxel-based analysis. This work aims to develop whole-body diffusion atlases of healthy volunteers scanned at 1.5T and 3T. Further aims include evaluating the atlases by establishing whole-body Apparent Diffusion Coefficient (ADC) values of healthy tissues and including healthy tissue deviations in an automated tumour segmentation task.

Methods

Multi-station whole-body Diffusion Weighted Imaging (DWI) and water-fat Magnetic Resonance Imaging (MRI) of healthy volunteers (n = 45) were acquired at 1.5T (n = 38) and/or 3T (n = 29), with test-retest imaging for five subjects per scanner. Using deformable image registration, whole-body MRI data was registered and composed into normal atlases. Healthy tissue ADCmean was manually measured for ten tissues, with test-retest percentage Repeatability Coefficient (%RC), and effect of age, sex and scanner assessed. Voxel-wise whole-body analyses using the normal atlases were studied with ADC correlation analyses and an automated tumour segmentation task. For the latter, lymphoma patient MRI scans (n = 40) with and without information about healthy tissue deviations were entered into a 3D U-Net architecture.

Results

Sex- and Body Mass Index (BMI)-stratified whole-body high b-value DWI and ADC normal atlases were created at 1.5T and 3T. %RC of healthy tissue ADCmean varied depending on tissue assessed (4–48% at 1.5T, 6–70% at 3T). Scanner differences in ADCmean were visualised in Bland-Altman analyses of dually scanned subjects. Sex differences were measurable for liver, muscle and bone at 1.5T, and muscle at 3T. Volume of Interest (VOI)-based multiple linear regression, and voxel-based correlations in normal atlas space, showed that age and ADC were negatively associated for liver and bone at 1.5T, and positively associated with brain tissue at 1.5T and 3T. Adding voxel-wise information about healthy tissue deviations in an automated tumour segmentation task gave numerical improvements in the segmentation metrics Dice score, sensitivity and precision.

Conclusions

Whole-body DWI and ADC normal atlases were created at 1.5T and 3T, and applied in whole-body voxel-wise analyses.

Background

Diffusion-Weighted Imaging (DWI) can be used to study the movement of water molecules, governed mainly by tissue cellularity, cell membrane integrity and fluid viscosity. It provides both visual and, by calculation of the Apparent Diffusion Coefficient (ADC), quantitative evaluations of tissue microcellular architecture. One usage area is in the diagnoses and longitudinal monitoring of cancer, with the ADC being a promising cancer imaging biomarker shown to inversely correlate with tumour cellularity [1]. With the introduction of the Diffusion-Weighted whole-body Imaging with Background body signal Suppression (DWIBS) technique, whole body tumour analysis has been made possible [2, 3]. High tumour to background contrast is obtained by using high diffusion sensitising gradient imaging, Short-TI Inversion Recovery (STIR) for fat suppression and a free breathing scan allowing for multiple signal averaging [4].

Statistical atlases have been constructed for a number of anatomical sites, providing population-based descriptions from multiple healthy controls and/or patients into single 3D representations using image registration. This approach has most extensively been used in the brain, for which single- or multi-modal representations of the healthy and diseased brain have been thoroughly investigated [5]. Averaging imaging features across individuals have identified group-specific patterns of brain structure. This approach has also been assessed in other single organ sites such as the heart [6], lung [7] and prostate [8]. For whole-body imaging, the approach of population-based atlases has been less studied. Medical image registration algorithms are in general purposely designed for specific body parts, with whole-body image registration being more challenging due to large inter-subject anatomical variations. Whole-body image registration algorithms have however been described [9,10,11] and a normal atlas for multi-modal 18F-Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET)/Magnetic Resonance Imaging (MRI) suggested [12]. The advantage of a whole-body atlas framework includes the potential of studying systemic diseases such as metabolic syndrome and cancer [13], without reducing the analysis to a set of pre-defined Regions of Interest (ROIs). There is also the potential for voxel-wise comparisons between patient scans and normative data.

Studies of healthy tissue ADC have been highlighted as vital for establishing the precision of ADC measurements [14]. Healthy tissue ADC assessments from whole-body DWI have been reported [15, 16], but are scarce.

Whole-body DWI allows cancer monitoring across the whole body, and is commonly evaluated qualitatively from high b-value images and quantitatively from lesion-wise ADC measurements. Using this approach, early response assessment has been shown possible in e.g. lymphoma [17]. Moving beyond the standard lesion-wise assessment of ADC, it has been suggested that other more advanced metrics can be used for improved tumour evaluation and response assessment. These include the total Diffusion Volume (tDV) for assessment of global disease burden [18] and histogram analysis of a single lesion or the total tumour burden for assessment of tumour spatial heterogeneity [19, 20]. For advanced measurements to be feasible, automated workflows for tumour segmentation are needed. Due to the high contrast between tumour and background, high b-value imaging is promising for this task. Blackledge et al. developed a semi-automated lesion segmentation approach using computed DWI (cDWI) [18]. To reduce image noise, this method was extended by Gatidis et al., who presented the voxel-wise cDWI (vcDWI) [21]. Information about voxel ADC is utilised in the vcDWI calculation, giving an improvement in signal and contrast to noise ratio, and a reduction in T2 shine-through effects. For fully automated tumour segmentation, supervised Convolutional Neural Network (CNN) based methods have recently been developed, with the most widely used architecture being the U-Net [22]. It has successfully been used to segment tumours in many cancers, including whole-body FDG PET applications. For DWI, U-Net has been used in single organ applications such as automatic segmentation of ischemic brain injury [23] and brain tumours [24]. To the best of our knowledge, it has yet to be applied to whole-body DWI. Large initiatives for automated tumour quantification in whole-body DWI using machine learning have however been described in e.g. myeloma [25].

This work aims to create, evaluate and employ a normal atlas of whole-body DWI and ADC of healthy volunteers scanned at 1.5T and 3T. The atlas is created using deformable image registration and evaluated by establishing whole-body ADC values of healthy tissues, including test-retest ADC measurements, comparison of ADC across field strengths and assessments of the effect of age and sex on ADC. We further employ the normal atlas in an automated tumour segmentation task, together with a deep learning approach, to investigate whether information about healthy tissue deviations could be advantageous in this task.

Methods

Subjects

In this prospective study, 45 healthy adult volunteers were recruited between January 2019 and February 2020 (mean age 45.3 ± 14.0 years, range 25–77 years, 23 females and 22 males). Ethics approval was obtained from the Uppsala regional ethics committee (Dnr 2017/524) and signed informed consent was obtained from all subjects before participation. Basal data including age, sex, height and weight were collected at time of imaging. The medical history of each subject was recorded, as well as any current medications. Exclusion criteria were contraindications to MR imaging (i.e. pacemaker, implanted devices, claustrophobia), contraindications to Buscopan administration, pregnancy and breast-feeding. Subjects with metal implants and known disease affecting the normal appearance of imaging (e.g. tumour disease) were not included. All subjects were asked to participate in scanning on two scanners. Five subjects per scanner were imaged using a test-retest protocol, with imaging repeated after a short toilet break.

To evaluate the atlas in an automated tumour segmentation task, a dataset of relapsed/refractory large B-cell lymphoma patients were included. This dataset contains 24 patients scanned longitudinally before and after therapy using Chimeric Antigen Receptor (CAR) T-cells. Patients scanned on PET/MRI and with measurable FDG-avid disease were included in the current study (n = 16, median age 63 years, range 37–71 years, 9 females and 7 males). A total of 40 PET/MRI scans were available, with each patient being scanned at 1–5 time points. Ethics approval was obtained from the Uppsala regional ethics committee (Dnr 2017/449) for retrospective data analysis.

Imaging

Imaging was performed with a 1.5T scanner (Achieva, Philips Healthcare, Best, The Netherlands, gradient system: 33 mT/m maximum amplitude, 180 T/m/s maximum slew rate) and a 3T scanner (Signa PET/MR, GE Healthcare, Milwaukee, WI, USA, gradient system: 44 mT/m maximum amplitude, 200 T/m/s maximum slew rate). Station-wise scan parameters are shown in Table 1. Healthy volunteers were scanned at 1.5T and 3T, while lymphoma patients were scanned at 3T. Bowel preparation consisted of ≥ 4 h fasting and, to minimise peristaltic movements, an intramuscular injection of 20 mg Hyoscine Butylbromide (Buscopan). Head volume and phased array body coils were used for signal reception, with subjects in a head first supine position. Multi-station whole-body images were acquired axially in free breathing using a water and fat MRI sequence and a diffusion-weighted spin echo Echo Planar Imaging (EPI) sequence with STIR fat suppression. Scan coverage was head to mid-thighs, corresponding to five or six stations per subject. For healthy volunteers, an EPI sequence with reverse phase encoding was also acquired to enable DWI geometric distortion correction using the Reverse Polarity Gradient (RPG) method [26, 27]. For lymphoma subjects, FDG PET imaging was included in the examination.

Table 1 Station-wise MR image acquisition parameters at 1.5T and 3T

ADC maps were calculated station-wise from b = 50, 400 and 900 s/mm2 images using a mono-exponential log-linear least square fit [28]. Water Fraction (WF) and Fat Fraction (FF) images were calculated from water and fat MRI [29]. Acquired stations were composed into single whole-body volumes by removing an equal number of overlapping slices from adjacent stations. Intensity blending was not performed. An experienced radiologist (HA) screened all healthy imaging data for incidental findings.

Image registration

An image registration pipeline was setup to spatially align whole-body water and fat MR images (Fig. 1) using the open source deform package [30]. In deform, deformable image registration is performed using a graph-cut based method, with a Gaussian smoothing multi-resolution strategy [9]. The registration algorithm utilises a patch-based setup, in which overlapping subsets of the 3D volume is registered and the results then combined. Tissue-specific regularisation weights are used, applied according to voxel-wise FF and WF content. As previously described [10], it is beneficial to set a higher regularisation for lean tissue (high WF) compared to adipose tissue (high FF), allowing for a larger inter-subject difference and higher elasticity of adipose tissue.

Fig. 1
figure 1

Image pre-processing (a) and registration pipeline (b), where iSAT mask corresponds to an inside SAT mask

Subjects were stratified according to sex and body mass index (BMI). Two male and two female reference subjects were chosen, one corresponding to the healthy weight BMI range (BMI < 25 kg/m2) and one corresponding to the overweight BMI range (BMI ≥ 25 kg/m2). The remaining healthy subjects’ water and fat MR images were registered to the relevant male or female reference spaces in a pre-processing and image registration pipeline as illustrated in Fig. 1.

In the pre-processing step, binary masks and a regularisation weight map were generated. To separate the body from background, binary body masks were automatically created using thresholding and standard morphological operations. Arm removal was needed due to non-standard arm positioning. Due to the large Subcutaneous Adipose Tissue (SAT) variability in the cohort, binary inside SAT masks were created using an active learning 2D U-Net [22]. After training, user input was needed to mark the start and end slice for the segmentation (armpit and minor trochanter). Furthermore, binary dilated body masks were created in reference space. The dilated body mask defined the region within which the registration cost function was calculated, making the registration faster by background removal. By using a dilated body mask, body edge information was passed to the registration algorithm, giving improved registration results. Compared to previous implementations of the registration pipeline [10, 12], the current pipeline employed a direct image registration method with a regularisation weight map created from reference subject WF and FF images.

The registration was performed in two-steps; pre-registration, and water and fat MRI registration. The pre-registration step included deformable registration of body and inside SAT masks. This step gave a rough alignment of whole-body volumes, with the resulting deformation field used as a starting guess in the following step. For the main registration, input data included water and fat MRI, binary masks, the regularisation weights map and the pre-registration deformation field. Optimal registration parameters were evaluated by calculating the Dice score between fixed and registered moving body masks, number of discontinuities in the Jacobian determinant map and inverse consistency in terms of vector magnitude error, as well as visual image quality assessments.

Taking advantage of the inherent co-registration of simultaneously acquired water and fat MRI and DWI, whole-body DWI and ADC data were transferred to the relevant reference space using the final deformation fields.

Normal atlases

The registered healthy volunteer data were combined into male and female normal atlases of normal and overweight BMI. For the DWI and ADC images, normal atlas versions with and without geometric distortion correction were created. The distortion corrected images were calculated using an open source framework [26, 31], as previously described [27].

ADC evaluation

Whole-body ADC was assessed for healthy volunteers. ADC was measured by manual Volume of Interest (VOI) segmentations of ten healthy tissues in 3DSlicer [32]. Tissues were selected as to span the whole body: parietal white matter, cerebellar white matter, liver (segment VI), spleen, kidneys, psoas muscle, vertebral body (L1-L5), pelvic bone (body of ilium), femur and thigh muscle. Multi-slice ROIs were manually placed in the tissue of interest by a medical physicist (TS), with three consecutive axial slices segmented for all tissues in male and female reference spaces, and with access to all imaging data. Circular ROIs were used, except for the spleen, kidneys and pelvic bone for which oval or crescent shaped ROIs were used. Right and left ROIs were used for white matter, kidneys, muscle, pelvic bone and femur, and then grouped. Additional File 1 shows representative slices of a reference subject at 3T with ROIs used to calculate ADCs for the ten different tissues. The segmentations were then transferred to each subject’s native space, visually assessed and, if needed, adjusted to exclude tissue borders, major vessels and incidental findings. For each subject and each tissue segmented, the multi-slice ROIs were combined into VOIs. For each VOI the mean ADC (ADCmean), median ADC (ADCmedian) and size were extracted from non-distortion corrected data.

Voxel-wise correlation between ADC and age was performed across the whole body in reference space. For this purpose, distortion corrected ADC data from all subjects were transformed to the BMI ≥ 25 kg/m2 male or female reference space, as applicable, using the registration pipeline illustrated in Fig. 1.

Tumour segmentation

For whole-body tumour segmentation, a state of the art 3D U-Net [33] was setup with two different network architectures. The baseline architecture included two input channels for DWI and WF data. For DWI data, it was assessed whether b = 900 s/mm2 or vcDWI data gave superior segmentation results according to the foreground Dice score. The second architecture was setup with three input channels: DWI, WF and t-map data. DWI data was the best performing data from the baseline model, while the t-map data included voxel-wise statistical deviations between normal atlas and lymphoma patient data (further described below).

WF data was prepared in range [0 1] and resampled to DW image size using linear interpolation. For b = 900 s/mm2 data, the signal intensity of the head station was normalised to the neck station signal intensity using histogram matching of overlapping slices [34] prior to combining stations into whole-bodies. The signal intensity of each whole-body DWI dataset was normalised using scaling to the upper quartile [35], followed by min-max normalisation to bring the data into range [0 1]. Max was set to the 99.99th percentile to avoid normalising to image noise.

For t-map data, the male or female atlas components were registered to the native space of each lymphoma patient (registration pipeline, Fig. 1). Patient data, in the form of smoothed (Gaussian, σ = 1.7 mm) b = 900 s/mm2 and vcDWI images, were then compared with the relevant atlas component using a voxel-wise one-sided t-test. This resulted in whole-body maps of p-values and t-scores (t-maps) based on b = 900 s/mm2 and vcDWI data. To decide which dataset to include as a third channel in the U-Net model, a few hard-coded rules were used: (i) threshold on p < 0.001, (ii) morphological opening to remove small detected clusters and (iii) removal of clusters with max signal intensity < 95th within-body percentile. To reduce false positives, it was further assessed whether removal of voxels belonging to adipose tissue (FF > 50%) gave improved results. The t-map of the dataset achieving the best mean foreground Dice score was included as a third channel in the 3D U-Net setup. This t-map was mapped from [0 200] to [0 1]. To further highlight tumour regions, it was also assessed whether multiplying the t-map with the corresponding normalised DWI data improved the segmentation performance. This t-map was mapped from [0 30] to [0 1].

Training was performed using five-fold cross-validation (4–9 scans per validation fold). 3D patches of size [x = 192, y = 192, z = 160] voxels were used for training, extracted using a sliding window with an overlap of 0.25 between successive patches. The Dice loss function was used for training optimisation (excluding the background) [36] with Adam optimiser and a learning rate of 1e− 4, a weight decay of 1e− 5 and a dropout factor of 0.20. Manual reference tumour segmentations were performed by two radiologists in consensus according to Lugano classification guidelines [37] and with access to water and fat MRI, DWI, ADC and FDG PET data.

The metrics extracted during five-fold cross validation were tDV, foreground Dice score, True Positive lesions (TP), False Positive lesions (FP), False Negative lesions (FN), sensitivity and precision. Lesion-wise sensitivity was defined as the number of correctly detected lesions (TP) divided by the total number of lesions (TP + FN), while lesion-wise precision was defined as the number of correctly detected lesions (TP) divided by the total number of detected lesions (TP + FP). Lesion-wise metrics were extracted from reference standard and predicted segmentations by connected components analysis, followed by thresholding on a cluster size of > 0.5 ml. A predicted lesion was counted as a TP for a Dice score > 0.01%, when compared to the reference standard segmentation.

Statistical analysis

The normal atlases are presented as the voxel-wise mean and percentage Coefficient of Variation (CV) for all atlas components. For healthy tissue VOI-based ADC measurements, summary statistics are presented in the form of mean, standard deviation (SD), median and interquartile range (IQR). Healthy tissue ADC differences due to sex were assessed by independent samples t-tests, while ADC repeatability was assessed using the percentage repeatability coefficient (%RC) for test-retest exams [38]. The effect of scanner on ADC was assessed using Bland-Altman statistics. Multiple linear regression was used to test if age and sex significantly predicted ADCmean for the VOI-based analysis, and Pearson correlation was used to assess the voxel-wise correlation between age and ADC for registered whole-body images in male and female reference spaces.

For the anomaly detection task, summary statistics are given as mean, SD, median and IQR.

Statistical significance was set at p < 0.05 and no correction for multiple comparisons was performed. Statistical analyses were performed using the open-source R software (v3.6.1.) or Python NumPy library.

Results

Subjects

Subject demographics are shown in Table 2. Of 45 recruited subject, 38 subjects were scanned at 1.5T (mean age 44.1 ± 15.0 years, 25–77 years, 17 females, 21 males) and 29 subjects were scanned at 3T (mean age 47.9 ± 15.0 years, 27–77 years, 13 females, 16 males). One recruited subject did not complete imaging due to claustrophobia. Current medications included blood pressure medication (n = 4), levothyroxine (n = 4), loperamide (n = 2), diabetes medication (n = 1), acetylsalicylic acid (n = 1) and mesalamine (n = 1). Test-retest scanning was performed for five subjects per scanner, with the median time between the start of each scan being 57 min (range 56–68 min) at 1.5T and 74 min (range 65–98 min) at 3T. Twenty-three subjects were scanned at both field strengths, with a median time of 13 weeks (range 0–40 weeks) between scans.

Normal atlases

Healthy subject water-fat MRI data were successfully registered to the relevant reference space. Representative coronal images for the mean and CV of the BMI ≥ 25 kg/m2 male atlases at 1.5T and 3T are shown in Fig. 2, while Table 2 shows the number of subjects and characteristics for each atlas component. Movies of all atlas components are provided as Additional Files 25. Good registration results were in general obtained, with organ borders well defined. Notably, the signal to noise ratio of b = 900 s/mm2 images were reduced at 1.5T compared to 3T, in particular seen for muscle tissue. An example of the effect of incorporating distortion correction in the atlas is shown in Fig. 3.

Fig. 2
figure 2

Example atlas images for male BMI ≥ 25 kg/m2 healthy volunteers scanned at 1.5T (n = 11, top) and 3T (n = 9, bottom). For each atlas, coronal WF, b = 900 s/mm2 and ADC images are shown. The top row corresponds to mean images, while the bottom row corresponds to the percentage CV. Geometric distortion correction was not performed for diffusion images

Table 2 Basic characteristics of the healthy subjects included in the atlas
Fig. 3
figure 3

Example of the effect of distortion correction on the 3T atlas. Mean sagittal images for females with BMI < 25 kg/m2, showing non-corrected ADC (a) and distortion-corrected ADC (b) data. The effect of the distortion correction is mainly visible for the spinal column, with discontinuities seen for non-corrected data as marked with an arrow. This is largely corrected for the distortion-corrected data

ADC evaluation

Summary statistics of ADCmean measured in tissues across the whole body are shown in Table 3, together with the segmented mean VOI size for each tissue, a comparison across sex and test-retest results in the form of %RC. Summary statistics for tissue ADCmedian are provided as Additional File 6. Overall, small numerical differences were measured between ADCmean and ADCmedian.

Sex differences were mainly measured at 1.5T, with statistically significant differences in ADCmean obtained for the liver (p = 0.045), psoas and thigh muscles (p < 0.001) and bones (femur p < 0.001, vertebral body p = 0.0047). At 3T, a significant sex difference in ADCmean was measured for thigh muscle only (p = 0.0042). The same effect of sex on ADC was seen in the multiple linear regression (Fig. 4). Age and/or sex predicted ADCmean for several healthy tissues, with Fig. 4 showing significant predictions (predictions not reaching statistical significance are shown as Additional File 7). At 1.5T, age was negatively associated with ADCmean for the liver, vertebral body and femur. At both field strengths, a positive association between age and ADCmean was obtained for parietal white matter.

Fig. 4
figure 4

Multiple linear regression fit to tissue ADCmean, with age and sex as explanatory variables. Significant results (p < 0.05) are shown for 1.5T (a-f) and 3T (g and h) data. For each tissue type, R2, model p-value, p-value for age, p-value for sex and regression equation are shown (female = 0, male = 1). Male and female measurement points are indicated in grey and black, respectively. Regression lines are shown with sex kept constant, with the grey lines corresponding to males and the black lines to females

The associations between age and ADC were confirmed in the voxel-wise whole body correlation analysis at 1.5T. As illustrated in Fig. 5 for female subjects, negative correlations between ADC and age were observed for e.g. liver, vertebral bodies and femur, and positive correlations between ADC and age were observed for brain tissue. Voxel-wise correlations between FF and age, and volume and age, are also shown in Fig. 5. Further results of voxel-wise correlation between ADC and age for female and male subjects at 1.5T and 3T are provided as Additional File 8. For males at 1.5T, the voxel-wise correlation between age and ADC showed the same trend as for females, but lower R-values were measured. At 3T, the positive correlation between ADC and brain tissue was visible in the voxel-wise analysis, but body regions had an overall noisy appearance.

Fig. 5
figure 5

Whole-body R-maps showing voxel-wise correlation between ADC and age for female subjects at 1.5T. The coronal image shows the correlation between ADC and age across the whole body (a). Example axial slices show age correlated with ADC (b, c), FF (d, e) and volume (f, g) with significant R-values (p < 0.05) overlayed on the atlas mean water image. Distortion corrected ADC data was used to produce the plots

Test-retest %RC varied depending on scanner used and tissue assessed (Table 3). Notably, a high repeatability was seen for the brain (%RC < 10% at 1.5T, %RC ≈ 10% at 3T). Muscle tissue had a high repeatability at 3T (psoas muscle 7.3%, thigh muscle 5.9%), but was lower at 1.5T (psoas muscle 48.1%, thigh muscle 34.9%). Also evident from Table 3, was the large differences in ADCmean measured at 1.5T and 3T. Bland-Altman plots including the 23 dually scanned subjects confirmed this (Additional File 9). Statistically significant differences between ADCmean measured at 1.5T and 3T were seen for all assessed tissues except the kidneys, pelvic bone and vertebral bodies.

Table 3 ADCmean (×10− 3 mm2/s) measured in 10 tissues across the whole body at 1.5T (top) and 3T (bottom)

Tumour segmentation

Results from the tumour segmentation task are shown in Table 4; Fig. 6, with predicted segmentations shown in Additional File 10. For the baseline model with two input channels, superior segmentation results in terms of Dice score were obtained for b = 900 s/mm2 input data (mean/median Dice = 38/40%, sensitivity/precision = 33/65%). For 12 scans (30%), all tumours were detected, with a median Dice score of 74% (range 23–90%) and median reference tDV of 39 ml (range 2-495 ml). For another 12 scans (30%), no tumours were detected, with median reference tDV of 9 ml (range 2–34 ml). The tDV in these patients was in general composed of one or several small tumours. Inferior segmentation results were seen for vcDWI data in terms of Dice score (mean/median Dice = 36/30%). A higher number of TPs were however detected, giving increased sensitivity (36%).

Fig. 6
figure 6

Manual reference and predicted tDV for all patients (left) and the change (Δ) in true positive lesions (TP) with ΔTP = TP(3 input channels)-TP(2 input channels) (right). Plots were produced for the b = 900 s/mm2 data for 2 input channels and the t-map×vcDWI data for 3 input channels

The dataset obtaining the best results in the voxel-wise segmentation approach using the normal atlas was vcDWI data, with FF voxels > 50% removed (mean Dice = 22%). Numerically, the three channel U-Net architecture performed better than the baseline U-Net architecture for all metrics assessed (Table 4, mean/median Dice = 40/45%, sensitivity/precision = 42/69%) as achieved when using the t-map multiplied with vcDWI as input data. For this model, all tumours were detected for 13 scans (33%), with median Dice score of 72% (range 1–92%) and median reference tDV of 33 ml (range 2-495 ml). For 9 scans (23%), no tumours were detected, with median reference tDV of 9 ml (range 2–34 ml). As for the baseline model, the tDV in these patients was in general composed of one or several small tumours.

Table 4 Tumour segmentation results for the 3D U-Net with two and three input channels

In general, predicted tDVs were smaller than manual reference tDVs (Fig. 6, left). The two U-Net architectures detected the same number of TPs for 24 scans (60%), with an increase in the number of TPs seen for 15 scans (38%) when using the U-Net with 3 input channels (Fig. 6, right). For both architectures, datasets with high b = 900 s/mm2 signal intensity in bone (n = 6, 15%) gave rise to approximately half of the false positives: n = 26 for 2 input channels with b = 900 s/mm2 data, and n = 39 for 3 input channels with t-map×vcDWI data.

Discussion

In this work, sex- and BMI-stratified whole-body DWI and ADC normal atlases were created at 1.5T and 3T. The atlases were used to study voxel-wise correlations between healthy tissue ADC and age across the whole body, confirming results from a manual segmentation approach. A deep learning based framework for automated tumour segmentation was setup. Statistical deviations between lymphoma subject and normal atlas DW images were shown to numerically improve Dice score, sensitivity and precision of this task.

The normal atlas was created using deformable image registration, building on a previously described method [9] and an open-source software [30]. Instead of performing the image registration in a step-wise manner for bone, adipose and lean tissue, as previously implemented, it has been observed that a voxel-wise regularisation weight map, imposing constraints on the regularisation term, can be included in the registration. This gives an improvement in terms of substantially reducing the number of fold-over artefacts in the Jacobian determinant map and speeds up the registration. In this work, it was further noted that a high variability in BMI poses challenges for the whole-body registration. This problem was minimised by using an inside SAT binary mask. Distortion corrected data was further utilised using the RPG method and was visually shown to improve the geometrical accuracy of the healthy atlases. This has been studied in more detail by others [27, 39].

Measured healthy tissue ADCmean values of this study were in line with those previously reported and obtained from whole-body DWI at 1.5T [15] and 3T [16]. Variations in the selection and number of b-values acquired in different studies however make direct comparisons of ADC difficult. It was possible to perform voxel-wise correlations between ADC and age across the whole body using the atlas. This was in particular evident at 1.5T for female subjects in bone regions and liver. This finding was confirmed by multiple linear regression analysis for manually segmented VOIs and are supported by previous studies for liver [16] and bone marrow [16, 40]. These results were however only seen at 1.5T, potentially due to the smaller number of subjects scanned at 3T. Sex differences in liver, bone and muscle were noted, with female subjects having higher ADCmean compared to men. These findings are also in line with published literature [16]. It has been suggested that ADC changes with age and sex in liver and bone marrow are due to changes in tissue fat content [16], with increased fat content seen for men compared to pre-menopausal women, and with increased age. This could however not be confirmed by the voxel-wise analysis performed in this study, for which a correlation between FF and age was not measurable.

A statistically significant association between ADC and age of parietal white matter was measured at both 1.5T and 3T. Although increased age has been shown to give increased water diffusion in white matter [41], the coarse image resolution in the current study made it difficult to measure white matter only without contamination from cerebrospinal fluid, which most likely affected the results.

Measurement precision is vital for longitudinal studies, to distinguish between measurement noise and true change in a biomarker of interest. ADC repeatability in localised areas of the body such as brain, prostate, breast and liver have been described in the Quantitative Imaging Biomarker Alliance (QIBA) diffusion imaging profile, but measurements of whole-body ADC repeatability is lacking [38]. This study showed that ADCmean repeatability varied in the studied tissues, with the %RC ranging from < 10% for the brain to 48% at 1.5T (liver and psoas muscle) and 70% at 3T (spleen). As such, depending on the position in the body and tissue type, a large percentage change in ADCmean is potentially needed for a true change to be measurable. The measured repeatability is however in the same range as figures reported in the literature. In the QIBA claim statement, %RC in the range 11–47% are given depending on organ. Notably, the %RC of muscle was in this study smaller at 3T compared to 1.5T (6–7% at 3T, 35–48% at 1.5T). This is possibly due to the improved signal to noise ratio offered at 3T. Evident from Fig. 2 and the b = 900 s/mm2 atlas image, the level of noise in muscle was larger at 1.5T compared to 3T.

Although the ADC has shown promise as an imaging biomarker, problems linked to its usage include protocol standardisation [14, 42]. Efforts have been made to standardise imaging protocols for obtaining reproducible biomarker measurements in DWI in general [38] and in whole-body scans [43]. Although this was a single-centre study, with acquisition protocols following current guidelines, evaluations of healthy tissues for subjects scanned at both 1.5T and 3T (n = 23) showed that large scanner differences in ADCmean exist for almost all studied tissues. The between-scanner ADC reproducibility, another aspect of precision, was hence low. The time between repeated scans were however long for a subset of subjects (median time 13 weeks, range 0–40 weeks), which is not ideal for measurements of reproducibility. The results however still highlights that large between-scanner differences can exist. A further aspect of standardisation is ADC measurement technique. In this work multiple-slice ROIs were used which has been shown to reduce ADC variability compared to using a single-slice ROI [44]. For reproducibility, the ROI placement used in this work is exemplified in Additional File 1.

An automated tumour segmentation framework was setup for whole-body DWI, in which information about statistical deviations from normality, in the form of t-maps, was shown to numerically improve the prediction performance in terms of foreground Dice score, sensitivity and precision. When creating t-maps, vcDWI data gave the best mean Dice for the predicted segmentations (22%). Usage of t-map data on its own, without a deep learning framework, was not feasible due to a large number of false positive voxels segmented by this approach. The false positives mainly stemmed from DWI signal artefacts, inter-subject signal intensity differences and registration errors. The U-Net was however able to use the t-maps to improve the Dice score and TPs of the predicted segmentations, with only a small increase in FPs.

Overall, automated tumour segmentation for this cohort proved challenging with inferior segmentation results compared to published literature for FDG PET whole body cancer applications [45]. The lymphoma dataset utilised included a limited number of scans and many small tumours with near normal ADC. These tumours were hardly visible in the high b-value diffusion images used for automated tumour segmentation, making this task very challenging. To a large extent, these small tumours were the reason for the U-Net not finding any tumours in a large proportion of scans (n = 12 for 2 input channels, n = 9 for 3 input channels). In an ongoing project, we have achieved a mean Dice of 36% for this cohort when FDG PET and WF data was used as input in the 2 input channels U-Net architecture. This can be compared to a mean Dice of 68% achieved for a larger dataset [46] using the same architecture (unpublished data). A further problem noted with usage of DWI data in general, was the increased signal intensity seen in the bone for a subset of patients, generating a large portion of the false positive tumours.

A general difficulty in MRI is that image signal intensities are arbitrary and do not have tissue-specific meaning. Although quantitative information in the form of the ADC can be obtained, high b-value images are preferentially used for tumour segmentation, and these are of a non-quantitative nature. This can potentially be problematic for the implementation of common post-processing techniques, such as segmentation and quantitation [47]. DWI data suffers from both within- and between-subject signal intensity variations. In general, signal reception is performed with different coils for the head and body, giving large within-subject signal differences. Histogram matching of overlapping slices [34] largely resolved this issue in the current study. Between-subject signal intensity variations for DWI data was to some extent rectified by upper quartile normalisation. Other normalisation methods were tested in this work, including min-max, Z-score and robust Z-score normalisation [35], but did not give improved segmentation results compared to upper quartile normalisation. There are however other signal intensity normalisation techniques that could be assessed, such as histogram-based methods [48].

Future work will include expanding the amount of training data and exploring synergistic effects of using multi-modal FDG PET and DWI data as input in the U-Net architecture. Between-scanner ADC and DWI signal intensity was in this study however shown to be large, and age and sex differences exist for a subset of organs. For multi-centre large-scale deep learning studies, often needed to provide sufficient training data, these factors might prove problematic. Improvements in normalisation techniques, and potentially age- and sex-matched studies, might be needed.

This study includes limitations. The number of subjects included was small, affecting the results of this paper, e.g. ADC repeatability measurements and the U-Net based tumour segmentation task. Due to scheduling issues and healthy subject availability, a long time interval was obtained between scans at 1.5T and 3T for a subset of the subjects, potentially affecting the ADC scanner comparison negatively. The tumour reference segmentations were based on access to FDG PET, DWI and water-fat data. It is possible that the U-Net would have performed better if reference segmentations had been performed on DWI and water-fat data only. Lastly, distortion corrected data for lymphoma patients was not available. This would have been preferable as the geometric distortion of DWI and ADC data can give large discrepancies between diffusion and structural imaging data. In future studies it might be clinically feasible to include distortion correction in a whole-body scanning protocol, as faster sequences for e.g. RPG distortion correction are becoming available [39].

Conclusion

Sex- and BMI-stratified whole-body DWI and ADC atlases were created at 1.5T and 3T. ADC repeatability varied depending on scanner and tissue assessed and healthy tissue ADC assessments showed large scanner differences, potentially posing challenges for multi-centre data pooling and analysis automation. The atlases were used to study voxel-wise correlations between healthy tissue ADC and age across the whole body, confirming results from a manual segmentation approach. Lastly, a framework for using the normal atlas in an automated tumour segmentation task was presented, with improved segmentation results in terms of Dice score, sensitivity and precision.

Data Availability

The healthy volunteer datasets collected and analysed, and the code generated, during the current study are available from the corresponding author on reasonable request.

Abbreviations

%RC:

Percentage Repeatability Coefficient

ADC:

Apparent Diffusion Coefficient

BMI:

Body Mass Index

CAR:

Chimeric Antigen Receptor

cDWI:

Computed DWI

CNN:

Convolutional Neural Network

CV:

Coefficient of Variation

DWI:

Diffusion Weighted Imaging

EPI:

Echo Planar Imaging

FDG:

F18-Fluorodeoxyglucose

FF:

Fat Fraction

FN:

False Negative

FOV:

Field of View

FP:

False Positive

MIP:

Maximum Intensity Projection

MRI:

Magnetic Resonance Imaging

PET:

Positron Emission Tomography

ROI:

Region of Interest

RPG:

Reverse Polarity Gradient

SAT:

Subcutaneous Adipose Tissue

STIR:

Short TI Inversion Recovery

tDV:

Total Diffusion Volume

TP:

True Positive

vcDWI:

Voxel-wise cDWI

VOI:

Volume of Interest

WF:

Water Fraction

References

  1. Chen L, Liu M, Bao J, Xia Y, Zhang J, Zhang L, et al. The correlation between Apparent Diffusion Coefficient and Tumor Cellularity in Patients: a Meta-analysis. PLoS ONE. 2013;8:e79008.

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Blackledge MD, Rata M, Tunariu N, Koh D-M, George A, Zivi A, et al. Visualizing whole-body treatment response heterogeneity using multi-parametric magnetic resonance imaging. JACT. 2016;10:290–301.

    Google Scholar 

  3. Padhani AR, Koh D-M, Collins DJ. Whole-body diffusion-weighted MR imaging in cancer: current status and research directions. Radiology. 2011;261:700–18.

    PubMed  Google Scholar 

  4. Takahara T, Imai Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med. 2004;22:275–82.

    PubMed  Google Scholar 

  5. Toga AW, Thompson PM, Mori S, Amunts K, Zilles K. Towards multimodal atlases of the human brain. Nat Rev Neurosci. 2006;7:952–66.

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Perperidis D, Mohiaddin RH, Rueckert D. Spatio-temporal free-form registration of cardiac MR image sequences. Med Image Anal. 2005;9:441–56.

    PubMed  Google Scholar 

  7. Li B, Christensen GE, Hoffman EA, McLennan G, Reinhardt JM. Establishing a normative atlas of the human lung: Intersubject Warping and Registration of volumetric CT images. Acad Radiol. 2003;10:255–65.

    PubMed  Google Scholar 

  8. Rusu M, Bloch BN, Jaffe CC, Rofsky NM, Genega EM, Feleppa E et al. Statistical 3D prostate imaging Atlas Construction via Anatomically Constrained Registration. Proc SPIE Int Soc Opt Eng. 2013;8669.

  9. Ekström S, Malmberg F, Ahlström H, Kullberg J, Strand R. Fast graph-cut based optimization for practical dense Deformable Registration of volume images. CMIG. 2020;84:101745.

    Google Scholar 

  10. Strand R, Malmberg F, Johansson L, Lind L, Sundbom M, Ahlström H, et al. A concept for holistic whole body MRI data analysis, Imiomics. PLoS ONE. 2017;12:e0169966.

    PubMed  PubMed Central  Google Scholar 

  11. Jönsson H, Ekström S, Strand R, Pedersen MA, Molin D, Ahlström H, et al. An image registration method for voxel-wise analysis of whole-body oncological PET-CT. Sci Rep. 2022;12:18768.

    PubMed  PubMed Central  Google Scholar 

  12. Sjöholm T, Ekström S, Strand R, Ahlström H, Lind L, Malmberg F, et al. A whole-body FDG PET/MR atlas for multiparametric voxel-based analysis. Sci Rep. 2019;9:1–10.

    Google Scholar 

  13. Hacker M, Hicks RJ, Beyer T. Applied Systems Biology-embracing molecular imaging for systemic medicine. Eur J Nucl Med Mol Imaging. 2020;47:2721–5.

    CAS  PubMed  Google Scholar 

  14. deSouza NM, Winfield JM, Waterton JC, Weller A, Papoutsaki M-V, Doran SJ, et al. Implementing diffusion-weighted MRI for body imaging in prospective multicentre trials: current considerations and future perspectives. Eur Radiol. 2018;28:1118–31.

    CAS  PubMed  Google Scholar 

  15. Jacobs MA, Macura KJ, Zaheer A, Antonarakis ES, Stearns V, Wolff AC, et al. Multiparametric whole-body MRI with diffusion-weighted imaging and ADC mapping for the identification of visceral and osseous metastases from solid tumors. Acad Radiol. 2018;25:1405–14.

    PubMed  PubMed Central  Google Scholar 

  16. Lavdas I, Rockall AG, Castelli F, Sandhu RS, Papadaki A, Honeyfield L, et al. Apparent diffusion coefficient of normal abdominal Organs and Bone Marrow from whole-body DWI at 1.5 T: the Effect of Sex and Age. AJR. 2015;205:242–50.

    PubMed  Google Scholar 

  17. Horger M, Claussen C, Kramer U, Fenchel M, Lichy M, Kaufmann S. Very early indicators of response to systemic therapy in lymphoma patients based on alterations in water diffusivity—A preliminary experience in 20 patients undergoing whole-body diffusion-weighted imaging. Eur J Radiol. 2014;83:1655–64.

    CAS  PubMed  Google Scholar 

  18. Blackledge MD, Collins DJ, Tunariu N, Orton MR, Padhani AR, Leach MO, et al. Assessment of treatment response by total tumor volume and global apparent diffusion coefficient using diffusion-weighted MRI in patients with metastatic bone disease: a feasibility study. PLoS ONE. 2014;9:e91779.

    PubMed  PubMed Central  Google Scholar 

  19. Donati OF, Mazaheri Y, Afaq A, Vargas HA, Zheng J, Moskowitz CS, et al. Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient. Radiology. 2014;271:143–52.

    PubMed  Google Scholar 

  20. Donners R, Yiin RSZ, Koh D-M, Paepe KD, Chau I, Chua S, et al. Whole-body diffusion-weighted MRI in lymphoma—comparison of global apparent diffusion coefficient histogram parameters for differentiation of diseased nodes of lymphoma patients from normal lymph nodes of healthy individuals. QIMS. 2021;11:3549–61.

    PubMed  PubMed Central  Google Scholar 

  21. Gatidis S, Schmidt H, Martirosian P, Nikolaou K, Schwenzer NF. Apparent diffusion coefficient-dependent voxelwise computed diffusion-weighted imaging: An approach for improving SNR and reducing T2 shine-through effects. J Magn Reson Imaging. 2016;43:824–32.

  22. Ronneberger O, Fischer P, Brox T, U-Net. Convolutional Networks for Biomedical Image Segmentation. In: Medical Image Computing and Computer-Assisted intervention. Lect Notes Comput Sci. 2015;9351:234–51.

    Google Scholar 

  23. Chen L, Bentley P, Rueckert D. Fully automatic acute ischemic lesion segmentation in DWI using convolutional neural networks. Neuroimage Clin. 2017;15:633–43.

    PubMed  PubMed Central  Google Scholar 

  24. Khorasani A, Kafieh R, Saboori M, Tavakoli MB. Glioma segmentation with DWI weighted images, conventional anatomical images, and post-contrast enhancement magnetic resonance imaging images by U-Net. Phys Eng Sci Med. 2022;45:925–34.

    PubMed  Google Scholar 

  25. Satchwell L, Wedlake L, Greenlay E, Li X, Messiou C, Glocker B, et al. Development of machine learning support for reading whole body diffusion-weighted MRI (WB-MRI) in myeloma for the detection and quantification of the extent of disease before and after treatment (MALIMAR): protocol for a cross-sectional diagnostic test accuracy study. BMJ Open. 2022;12:e067140.

    PubMed  PubMed Central  Google Scholar 

  26. Holland D, Kuperman JM, Dale AM. Efficient correction of inhomogeneous static magnetic field-induced distortion in Echo Planar Imaging. NeuroImage. 2010;50:175–83.

    PubMed  Google Scholar 

  27. Sjöholm T, Kullberg J, Strand R, Engström M, Ahlström H, Malmberg F. Improved geometric accuracy of whole body diffusion-weighted imaging at 1.5T and 3T using reverse polarity gradients. Sci Rep. 2022;12:11605.

    PubMed  PubMed Central  Google Scholar 

  28. Blackledge MD, Tunariu N, Zugni F, Holbrey R, Orton MR, Ribeiro A, et al. Noise-Corrected, exponentially weighted, diffusion-weighted MRI (niceDWI) improves Image Signal Uniformity in whole-body imaging of metastatic prostate Cancer. Front Oncol. 2020;10:704.

    PubMed  PubMed Central  Google Scholar 

  29. Berglund J, Johansson L, Ahlström H, Kullberg J. Three-point Dixon method enables whole-body water and fat imaging of obese subjects. Magn Reson Med. 2010;63:1659–68.

    PubMed  Google Scholar 

  30. Ekström S. deform [Internet]. 2022 [cited 2022 Nov 27]. Available from: https://github.com/simeks/deform.

  31. Rohlfing T. Unwarping Echo Planar Images Using CMTK. [Internet]. [cited 2023 Jan 18]. Available from: www.nitrc.org/docman/view.php/212/1187/UnwarpEchoPlanar.pdf.

  32. Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin J-C, Pujol S, et al. 3D slicer as an image computing platform for the quantitative imaging network. Magn Reson Imaging. 2012;30:1323–41.

    PubMed  PubMed Central  Google Scholar 

  33. Cicek Ö, Abdulkadir A, Lienkamp SS, Brox T, Ronneberger O, et al. 3D U-Net: learning dense volumetric segmentation from sparse annotation. In: Medical Image Computing and Computer-Assisted intervention. Lect Notes Comput Sci. 2016;9901:424–32.

    Google Scholar 

  34. Blackledge MD, Koh D-M, Padhani AR, Stirling JJ, Taylor NJ, Collins DJ et al. The feasibility of evaluating treatment response of bone metastases by segmenting tumor diffusion volumes to estimate total disease burden on whole body diffusion-weighted imaging. Proceedings of the ISMRM. 2012, abstract #255.

  35. Castaldo R, Pane K, Nicolai E, Salvatore M, Franzese M. The impact of normalization approaches to automatically detect Radiogenomic Phenotypes characterizing breast Cancer receptors Status. Cancers. 2020;12:518.

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Sudre CH, Li W, Vercauteren T, Ourselin S, Cardoso MJ. Generalised dice overlap as a deep learning loss function for highly unbalanced segmentations. In: deep learning in Medical Image Analysis and Multimodal Learning for clinical decision support. Lect Notes Comput Sci. 2017;10553:240–8.

    Google Scholar 

  37. Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32:3059–68.

    PubMed  PubMed Central  Google Scholar 

  38. Shukla-Dave A, Obuchowski NA, Chenevert TL, Jambawalikar S, Schwartz LH, Malyarenko D, et al. Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE-MRI derived biomarkers in multicenter oncology trials. J Magn Reson Imaging. 2019;49:e101–21.

    PubMed  Google Scholar 

  39. Digma LA, Feng CH, Conlin CC, Rodríguez-Soto AE, Zhong AY, Hussain TS, et al. Correcting B0 inhomogeneity-induced distortions in whole-body diffusion MRI of bone. Sci Rep. 2022;12:265.

    PubMed  PubMed Central  Google Scholar 

  40. Herrmann J, Krstin N, Schoennagel BP, Sornsakrin M, Derlin T, Busch JD, et al. Age-related distribution of vertebral bone-marrow diffusivity. Eur J Radiol. 2012;81:4046–9.

    PubMed  Google Scholar 

  41. Engelter ST, Provenzale JM, Petrella JR, DeLong DM, MacFall JR. The effect of aging on the apparent diffusion coefficient of normal-appearing white matter. AJR. 2000;175:425–30.

    CAS  PubMed  Google Scholar 

  42. Padhani AR, Liu G, Mu-Koh D, Chenevert TL, Thoeny HC, Takahara T, et al. Diffusion-weighted magnetic resonance imaging as a Cancer Biomarker: Consensus and Recommendations. Neoplasia. 2009;11:102–25.

    CAS  PubMed  PubMed Central  Google Scholar 

  43. Barnes A, Alonzi R, Blackledge M, Charles-Edwards G, Collins DJ, Cook G, et al. UK quantitative WB-DWI technical workgroup: consensus meeting recommendations on optimisation, quality control, processing and analysis of quantitative whole-body diffusion-weighted imaging for cancer. Br J Radiol. 2018;91:20170577.

    PubMed  Google Scholar 

  44. Miquel ME, Scott AD, Macdougall ND, Boubertakh R, Bharwani N, Rockall AG. In vitro and in vivo repeatability of abdominal diffusion-weighted MRI. Br J Radiol. 2012;85:1507–12.

    CAS  PubMed  PubMed Central  Google Scholar 

  45. Hasani N, Paravastu SS, Farhadi F, Yousefirizi F, Morris MA, Rahmim A, et al. Artificial Intelligence in Lymphoma PET Imaging:: a scoping review (current Trends and future directions). PET Clin. 2022;17:145–74.

    PubMed  PubMed Central  Google Scholar 

  46. Gatidis S, Hepp T, Früh M, La Fougère C, Nikolaou K, Pfannenberg C, et al. A whole-body FDG-PET/CT dataset with manually annotated Tumor Lesions. Sci Data. 2022;9:601.

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Lavdas I, Glocker B, Rueckert D, Taylor SA, Aboagye EO, Rockall AG. Machine learning in whole-body MRI: experiences and challenges from an applied study using multicentre data. Clin Radiol. 2019;74:346–56.

    CAS  PubMed  Google Scholar 

  48. Madabhushi A, Udupa JK. New methods of MR image intensity standardization via generalized scale. Med Phys. 2006;33:3426–34.

    PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank MR research technologists Anders Lundberg, Gunilla Arvidsson, Marie Åhlman, Anne-Marie Montelius and Caroline Lybeck for their aid in image acquisition, and MD Hanna Jönsson for administering Buscopan to healthy volunteers.

Funding

Open access funding provided by Uppsala University. Swedish Cancer Society 20 1303PjF (HA). Antaros Medical AB.

Open access funding provided by Uppsala University.

Author information

Authors and Affiliations

Authors

Contributions

Study concept and design: TS, FM, RS, JK, HA. Data acquisition healthy volunteers: TS, JK, HA. Data acquisition lymphoma subjects: GE, HA. Image analysis: TS, ST, AK. Interpretation of results: TS, JK. Manuscript preparation: TS, Manuscript revision, reading and approval of the final manuscript: all authors.

Corresponding author

Correspondence to Joel Kullberg.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the Uppsala Regional Ethics Review Board, with reference number Dnr 2017/524 for the healthy volunteer cohort and Dnr 2017/449 for the lymphoma cohort. All subjects gave their informed written consent to participate.

Consent for publication

Not applicable.

Competing interests

JK and HA are co-founders of Antaros Medical AB. There are patents registered for whole-body MRI and CT image registration, Antaros Medical owns the rights to related patented and patent pending image registration technology (SE1400537A, EP21169609A).

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1. Additional file 1 contains example ROIs outlined in reference space (AdditionalFile1.pdf).

40644_2023_603_MOESM2_ESM.avi

Supplementary Material 2. Additional files 2-5 contain movie of the male and female normal atlases at 1.5T and 3T (AdditionalFile_2.avi, AddionalFile_3.avi) and 3T (Additionalfile_4.avi, AddionalFile_5.avi).

Supplementary Material 3

Supplementary Material 4

Supplementary Material 5

40644_2023_603_MOESM6_ESM.pdf

Supplementary Material 6. Additional file 6 is a table of ADCmedian measured in 10 tissue across the whole body (AdditionalFile6.pdf)

40644_2023_603_MOESM7_ESM.pdf

Supplementary Material 7. Additional file 7 contains a figure showing the multiple linear regression fit to tissue ADCmean, with age and sex as explanatory variables, and p > 0.05 (AdditionalFile7.pdf)

40644_2023_603_MOESM8_ESM.pdf

Supplementary Material 8. Additional file 8 shows example whole-body R-maps for male and female subjects at 1.5T and 3T (AdditionalFile8.pdf)

40644_2023_603_MOESM9_ESM.pdf

Supplementary Material 9. Additional file 9 contains Bland-Altman plots for dually scanned healthy volunteers at 1.5T and 3T (AdditionalFile9.pdf)

40644_2023_603_MOESM10_ESM.pdf

Supplementary Material 10. Additional file 10 shows predicted tumours overlayed on b = 900 s/mm2 MIPs (AdditionalFile_10.pdf)

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sjöholm, T., Tarai, S., Malmberg, F. et al. A whole-body diffusion MRI normal atlas: development, evaluation and initial use. Cancer Imaging 23, 87 (2023). https://doi.org/10.1186/s40644-023-00603-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s40644-023-00603-5

Keywords